表纸
年间契约型资讯服务

FirstWord Pharma PLUS:全球制药行业新闻服务

FirstWord Pharma PLUS

出版商 FirstWord 商品编码 282161
出版日期 年间契约型资讯服务 内容资讯 英文
价格
如有价格方面的疑问请按下「询问」键来信查询
FirstWord Pharma PLUS:全球制药行业新闻服务 FirstWord Pharma PLUS
出版日期: 年间契约型资讯服务内容资讯: 英文
简介

FirstWord Pharma PLUS 是制药行业新闻和信息的全球领先服务,并介绍引起全球关注的新闻,见解,分析和意见。这样,我们将帮助制药行业的相关人员始终获取最新信息。

用户可以不受限制地访问 FirstWord Pharma 新闻服务,而自定义工具可让您过滤与您最相关的信息。可以为您的用户定制此服务,从而节省您的时间和金钱。

FirstWord Pharma PLUS功能

  • 无限方便地访问各种过去和现在的制药行业新闻,其便捷的搜索工具可帮助您快速查找和保存信息。
  • 通过每日 Top Story 新闻摘要一目瞭然地获取每日新闻。汇集了500多种制药/生物技术新闻和期刊文章/摘要。
  • 通过易于使用的主题类别显示其他内容,例如公司新闻,特定条件,产品,受监管的市场,医学杂志。
    无限访问
  • FirstWord ViewPoints 聚焦于文章。这将为您提供更深入的分析和专家见解,从而加深您的知识。
  • 您可以选择和过滤最感兴趣的区域。
    • 您可以按照自己的方式安排新闻服务。您可以筛选出有关行业主题的概述,也可以筛选出以关注最感兴趣的领域。
  • 随时随地获取最新信息。
    • FirstWord Pharma PLUS 可以通过多种方法进行访问,包括网站,电子邮件通讯,RSS提要,Twitter,移动设备,平板电脑,智能手机和播客。我能做到。
  • 可以从一个来源获得各种新闻。
    • 获取超过15个市场的行业新闻,包括美国,欧盟,日本,巴西,印度和中国。
目录

5 Reasons FirstWord Pharma PLUS is Your Leading Pharma News Service:

  • 1. Choose the news you want to see: Customizable content--monitor the products, companies, medical conditions, therapeutic areas, and regulatory agencies that are of importance to you and your company.
  • 2. Dig deeper with related analysis: Original insight, analysis, and views articles provide you with timely innovative thinking and credible intelligence on major news developments, issues, and events.
  • 3. Count on comprehensive coverage: 8,000 worldwide news sources, 2,400 medical journals, 130 medical conferences, 145 regulatory bodies. Track over 15,000 products, 5,000 companies, 130 medical conditions with over 10 years of searchable news archives.
  • 4. Our trusted editorial team: FirstWord Pharma's editorial team reviews all stories for accuracy, timeliness, and relevance before content is published. FirstWord standards and processes ensure the news selection and publishing is unbiased, providing you with a news service that you can trust.
  • 5. We'll see you there: Live attendance of 130+ international medical meetings with dispatches published within hours of the sessions ending plus presence at major industry conferences.

Insight, Analysis and Views:

Physician Views

  • Physician polls that deliver timely market feedback on developments such as the impact of product approvals and pending approvals.

KOL Views

  • Interviews with leading KOLs to get their authoritative and considered take on therapy developments in the news.

ViewPoints

  • Analysis and views from industry experts driven by top news events in pharma.

Friday Five

  • Highlights the five key takeaways stories or events, from the past week.